Adaptimmune Therapeutics plc

ADAPY ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
RW Apr 22, 2026 RW
SCHEDULE 13G Feb 17, 2026
EFFECT Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
424B3 Nov 13, 2025
15-12G Nov 13, 2025 15-12G
S-8 POS Oct 28, 2025 S-8 POS
S-8 POS Oct 28, 2025 S-8 POS
S-8 POS Oct 28, 2025 S-8 POS
POS AM Oct 28, 2025 POS AM
25 Oct 28, 2025 FORM 25
8-K Oct 20, 2025 8-K
3 Oct 8, 2025 OWNERSHIP DOCUMENT
8-K Sep 26, 2025 8-K
8-K Sep 12, 2025 8-K
8-K Sep 8, 2025 8-K
4 Sep 3, 2025 OWNERSHIP DOCUMENT
144 Sep 2, 2025
4 Aug 29, 2025 OWNERSHIP DOCUMENT
144 Aug 29, 2025
8-K Aug 29, 2025 8-K
4 Aug 19, 2025 4
SCHEDULE 13D/A Aug 19, 2025
SCHEDULE 13G/A Aug 19, 2025
8-K Aug 15, 2025 8-K
← Newer Page 1 of 33 · 808 filings Older →